Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04774718
Title	A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Hoffmann-La Roche
Indications	central nervous system cancer Advanced Solid Tumor
Therapies	Alectinib
Age Groups:	child
Covered Countries	USA \| ITA \| GBR \| FRA \| ESP \| DEU \| CAN \| AUS